With the first CONSIGMA™ barely installed at a Top-10 pharmaceutical company for production of a blockbuster drug, Collette has received a second order for this innovative continuous high-shear granulation and drying system from another Top-10 company for development of new medicines.
The main driver for this company to select the CONSIGMA™ technology is the fact that there is no need for scale-up with this technology, as the difference between R & D batches and production batches is the time during which the machine runs. This has another advantage that this company deemed very important, which is the fact that CONSIGMA™ can produce any batch size needed.
For more information about these and other advantages, please visit www.consigma.be or contact Collette.